X

Clinical Trials

Contact Us

URCC 18007

Study Number: URCC 18007

This phase III trial studies how well bupropion works in reducing cancer related fatigue in stage I-III breast cancer survivors. Bupropion is a drug that is used to treat depression, as well as to help people quit smoking. Cancer and its treatment can cause fatigue. Giving bupropion may improve cancer related fatigue in breast cancer survivors.

Contact Person(s)
  • MBMC, Kim Cerrone, 314-996-5872
  • Lisa Johnson, 314-996-5888

View More Information - This link will take you to clinicaltrials.gov for specific study information including eligibility criteria. A full list of participating institutions can also be found on this page.